Zhongmou Therapeutics
Clinical trials sponsored by Zhongmou Therapeutics, explained in plain language.
-
New eye injection trial hopes to slow vision loss in rare disease
Disease control Recruiting nowThis early-stage trial tests whether an injection called ZM-02 is safe for people with retinitis pigmentosa, a genetic condition that causes vision loss. Twelve participants with very poor vision will receive one injection in one eye. The main goal is to check for side effects, n…
Phase: EARLY_PHASE1 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated May 26, 2026 07:44 UTC
-
New color test for Low-Vision patients under study
Knowledge-focused Recruiting nowThis study looks at how color vision loss progresses in people with inherited retinal diseases (IRDs) and how it relates to changes in the retina. Researchers will test a new color vision test designed for people with very low vision. The study involves 200 participants, includin…
Sponsor: Zhongmou Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 07:24 UTC